rosiglitazone has been researched along with Embolus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ding, X; He, C; Noor, R; Pegg, C; Shuaib, A; Wang, CX | 1 |
1 other study(ies) available for rosiglitazone and Embolus
Article | Year |
---|---|
Rosiglitazone alone or in combination with tissue plasminogen activator improves ischemic brain injury in an embolic model in rats.
Topics: Animals; Brain Ischemia; Collagen Type IV; Disease Models, Animal; Drug Therapy, Combination; Embolism; Hypoglycemic Agents; Matrix Metalloproteinase 9; Middle Cerebral Artery; Neuroprotective Agents; PPAR gamma; Rats; Rosiglitazone; Thiazolidinediones; Tissue Plasminogen Activator; Treatment Outcome | 2009 |